Status:
COMPLETED
AML Electronic Decision Aid
Lead Sponsor:
Duke University
Collaborating Sponsors:
American Cancer Society, Inc.
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test the feasibility and preliminary efficacy of a novel electronic decision aid to improve AML patients' understanding of their illness, prognosis, and treatment optio...
Detailed Description
The purpose of this study is to test the feasibility and preliminary efficacy of a novel electronic decision aid to improve AML patients' understanding of their illness, prognosis, and treatment optio...
Eligibility Criteria
Inclusion
- At least age 18
- Capacity to give consent
- Diagnosis of acute myeloid leukemia (AML)
- Fluent in English
- Receiving care at Duke, and fits into one of the following scenarios:
- has not yet made a treatment decision (in the DCI clinics or on the inpatient wards),
- have recently made a decision (in the last 6 weeks), and are admitted for chemotherapy on 9100 or in the oncology treatment center to receive outpatient therapy,
- or, during remission, while receiving consolidation chemotherapy in the hospital
Exclusion
- Patients too sick to participate per clinician discretion
Key Trial Info
Start Date :
February 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03442452
Start Date
February 7 2018
End Date
February 1 2019
Last Update
October 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710